After reading this note you will be able to define raised intracranial pressure (ICP), list the common Kenyan aetiologies, describe the clinical picture and examination clues, interpret the key investigations and outline the immediate and definitive management steps (always verify drug choices and local protocols against the Kenya MoH guideline and your hospital formulary).
Definition
Raised intracranial pressure is a sustained increase in the pressure within the cranial vault above the normal range of 5‑15 mm Hg in adults, sufficient to compromise cerebral perfusion, produce neurological signs, or cause herniation.
Anatomy and physiology you need
| Structure | Relevance to ICP |
|---|---|
| Brain parenchyma | Volume of tissue; swelling directly raises pressure |
| Cerebrospinal fluid (CSF) | Produced in choroid plexus, circulates in ventricles & subarachnoid space; excess or obstruction raises pressure |
| Intracranial blood volume | Arterial inflow and venous outflow; venous congestion adds to pressure |
| Rigid skull | Fixed volume; according to Monro‑Kellie doctrine, increase in one component must be offset by decrease in another or pressure rises |
| Dura mater & venous sinuses | Major pathways for CSF absorption and venous drainage; thrombosis impairs outflow |
| Brainstem | Houses vital centres; herniation here is life‑threatening |
Causes and risk factors
| Category | Common Kenyan examples |
|---|---|
| Space‑occupying lesions | Large tuberculoma, cerebral abscess (bacterial, fungal, malaria‑related), primary brain tumour, metastatic disease |
| Hydrocephalus | Obstructive (e.g., aqueductal stenosis from TB meningitis), communicating (post‑meningitic scarring) |
| Cerebral edema | Severe cerebral malaria, hypoxic‑ischemic injury, hypertensive encephalopathy, neuro‑toxicity (e.g., antiretroviral drug toxicity) |
| Vascular lesions | Subarachnoid haemorrhage (trauma, ruptured aneurysm), intracerebral haemorrhage (hypertension, sickle‑cell vaso‑occlusion) |
| Venous outflow obstruction | Cerebral venous sinus thrombosis (often associated with HIV, pregnancy, dehydration) |
| Infections & inflammation | HIV encephalopathy, cryptococcal meningitis, TB meningitis, bacterial meningitis |
| Metabolic / systemic | Severe hyponatraemia, hepatic encephalopathy, renal failure uremia, severe anaemia in sickle‑cell disease |
Risk factors specific to our setting include HIV infection, TB exposure, malaria endemicity, sickle‑cell disease prevalence, and limited access to early neuro‑imaging.
Pathophysiology
- Initial insult (e.g., infection, tumour, haemorrhage) →
- Increase in intracranial volume (mass effect, oedema, CSF accumulation) →
- Monro‑Kellie imbalance (fixed skull volume cannot accommodate extra volume) →
- Rise in ICP →
- Reduced cerebral perfusion pressure (CPP = MAP – ICP) →
- Ischaemia & further oedema (vicious cycle) →
- Brain herniation if compensatory mechanisms exhausted.
Each step amplifies the next, explaining why early control of ICP is critical.
Clinical features
| History element | Why it matters |
|---|---|
| Onset and progression – sudden (e.g., hemorrhage) vs. insidious (e.g., tumor, chronic hydrocephalus) | Helps differentiate acute life‑threatening causes from sub‑acute or chronic processes. |
| Headache – often described as “worst ever”, worse on waking, aggravated by coughing or Valsalva | Raised ICP stretches pain‑sensitive dura and meningeal vessels; positional change alters pressure. |
| Nausea / vomiting – especially projectile, without nausea, often early morning | Vomiting is a brainstem reflex to pressure on the medullary vomiting centre; lack of nausea suggests central origin. |
| Visual disturbances – blurred vision, transient loss, double vision, papilledema | Papilledema reflects chronic elevation of ICP; cranial nerve VI palsy (abducens) is the classic false‑localising sign. |
| Altered consciousness – from lethargy to coma | Progressive compression of the reticular activating system as ICP rises. |
| Seizures – new‑onset focal or generalized | Cortical irritation from mass effect, edema or infection. |
| Focal neurological deficits – weakness, sensory loss, aphasia | Local mass effect or infarction; helps localise the lesion. |
| Recent infection or systemic illness – TB, malaria, HIV‑related opportunistic infections, sickle‑cell vaso‑occlusive crisis | Many tropical infections produce space‑occupying lesions or cerebral edema. |
| Trauma history – recent head injury, fall, road‑traffic accident | Traumatic brain injury is a leading cause of acute ICP rise. |
| Medication / substance use – steroids, diuretics, antiretrovirals, traditional medicines | Some drugs can precipitate cerebral edema (e.g., rapid steroid withdrawal) or mask symptoms. |
| Pregnancy – especially in the third trimester | Venous congestion and hormonal changes can worsen ICP in pre‑existing lesions. |
Examination findings and their pathophysiology
| Finding | Mechanism |
|---|---|
| Altered level of consciousness (GCS <15) | Direct compression of the ascending reticular activating system. |
| Papilledema (bilateral optic disc swelling) | Increased subarachnoid pressure transmitted to the optic nerve sheath, impeding axoplasmic flow. |
| Cranial nerve VI palsy (horizontal diplopia) | The abducens nerve has a long intracranial course; it is stretched by raised pressure. |
| Cushing’s triad (hypertension, bradycardia, irregular respirations) | Autonomic response to maintain cerebral perfusion when ICP approaches MAP. |
| Motor weakness (upper motor neuron pattern) | Compression of corticospinal tracts by a mass or edema. |
| Sensory level (e.g., loss below a spinal segment) | Downward herniation compressing the spinal cord or brainstem. |
| Seizure activity (post‑ictal confusion) | Cortical irritation from edema or lesion. |
| Meningeal signs (neck rigidity) – only if meningitis or subarachnoid bleed | Irritation of the meninges by blood or inflammatory exudate. |
| Focal scalp tenderness (overlying tumour) | Local inflammation or tumour invasion of periosteum. |
| Signs of systemic infection (fever, tachycardia) | Underlying infectious aetiology (TB meningitis, cerebral malaria). |
Differential diagnosis
| Condition | Points to it | How it separates from raised ICP |
|---|---|---|
| Acute subdural haematoma | Head trauma, rapid decline, unilateral pupil dilation | CT shows crescent‑shaped bleed; often focal mass effect |
| Cerebral malaria | Recent travel, fever, anaemia, sickle‑cell disease | Peripheral parasitaemia, rapid response to antimalarials |
| Tuberculous meningitis | HIV, TB exposure, chronic headache, cranial nerve palsies | CSF with lymphocytic pleocytosis, basal meningeal enhancement |
| Brain tumour (e.g., astrocytoma) | Progressive symptoms, seizures, focal deficits | MRI shows enhancing mass, often slower onset |
| Cerebral venous sinus thrombosis | Pregnancy, oral contraceptives, sickle‑cell disease | MRV shows venous occlusion, often with hemorrhagic infarcts |
| Hydrocephalus (communicating or obstructive) | History of meningitis, shunt malfunction | Enlarged ventricles on imaging, often without focal mass |
| Hypertensive encephalopathy | Severe hypertension, headache, visual changes | MRI shows posterior reversible leukoencephalopathy, no mass |
Investigations
| Test | What it answers | Typical result interpretation |
|---|---|---|
| Non‑contrast CT head | Acute bleed, mass effect, hydrocephalus | Hyperdense bleed, midline shift, ventricular size |
| MRI brain with contrast | Tumour character, infection, demyelination | Enhancing lesion, meningeal enhancement, diffusion restriction |
| Lumbar puncture (after imaging) | Infective aetiology, CSF pressure | Elevated opening pressure, lymphocytic pleocytosis in TB |
| CSF analysis (cell count, protein, glucose, PCR) | Specific pathogen identification | Low glucose, high protein in TB; malaria parasites if present |
| Fundoscopy (direct or indirect) | Presence of papilledema | Swollen optic disc with blurred margins |
| Electrolytes & serum osmolality | Rule out metabolic causes, guide osmotherapy | Hyponatraemia may suggest SIADH; high osmolality needed for hypertonic therapy |
| Blood cultures & malaria smear | Systemic infection, malaria | Positive cultures for bacterial sepsis; parasites on smear |
| HIV test & CD4 count | Underlying immunosuppression | Low CD4 predisposes to opportunistic CNS lesions |
Diagnosis and severity
- Confirm raised ICP – clinical triad (headache, vomiting, papilledema) plus objective evidence on imaging (midline shift > 5 mm, effacement of sulci, compressed ventricles) or elevated CSF opening pressure (> 250 mm H₂O).
- Classify severity (based on clinical and radiological criteria):
| Severity | Clinical picture | Imaging clues |
|---|---|---|
| Mild | Alert, GCS ≥ 14, no Cushing’s signs, papilledema absent or early | Small mass effect, ventricles normal size |
| Moderate | Drowsy, GCS 13‑14, early Cushing’s response, papilledema present | Midline shift 5‑10 mm, compressed cisterns |
| Severe | Coma (GCS ≤ 8), full Cushing’s triad, bilateral fixed pupils possible | Shift > 10 mm, herniation signs, obliterated basal cisterns |
- Assign a working aetiology – integrate history, exam, and investigations (e.g., “TB meningitis with hydrocephalus” or “malaria‑related cerebral edema”).
- Document – time of symptom onset, progression, GCS trend, pupil size/reactivity, vital signs, and imaging measurements. This baseline guides monitoring and therapeutic thresholds.
The above framework equips the junior doctor to recognise, prioritise, and act on raised intracranial pressure in the Kenyan clinical setting, where infectious, haematologic, and traumatic aetiologies are common.
Management
Immediate stabilisation
| Step | What to do | Rationale |
|---|---|---|
| Airway & breathing | Position head 30° – 45° (unless cervical spine injury), give 100 % O₂, secure airway if GCS ≤ 8 | Improves venous outflow, prevents hypoxia which worsens cerebral edema |
| Circulation | Maintain MAP ≥ 65 mmHg (or SBP ≥ 90 mmHg) with isotonic fluids; avoid hypotension | Cerebral perfusion pressure = MAP – ICP; low MAP → ischemia |
| Hyperventilation (short‑term) | Bag‑mask ventilation to achieve PaCO₂ ≈ 30 mmHg for ≤ 30 min | Lowers ICP by cerebral vasoconstriction; only a bridge to definitive therapy |
| Osmotherapy (first line) | Give mannitol or hypertonic saline bolus | Creates osmotic gradient, draws water out of brain tissue |
| Analgesia & sedation | Short‑acting agents (e.g., fentanyl, propofol) to blunt pain‑induced ICP spikes | Reduces sympathetic surge and ICP elevation |
| Anticonvulsants (if seizure risk) | Load with a broad‑spectrum agent (e.g., levetiracetam) | Prevents secondary injury from seizures |
Definitive treatment
- Treat the underlying cause –
- Bacterial meningitis → high‑dose IV ceftriaxone + vancomycin (adjust for local resistance).
- Tuberculous meningitis → intensive phase with rifampicin, isoniazid, pyrazinamide, ethambutol + adjunctive steroids.
- Cerebral malaria → IV artesunate.
- Space‑occupying lesion (tumour, abscess) → neurosurgical decompression or aspiration.
- HIV‑related CNS lymphoma → chemo‑radiotherapy after biopsy.
- Sustained ICP control –
- Continue osmotherapy as needed, titrating to serum osmolality.
- Consider continuous CSF drainage via external ventricular drain if ventricles are accessible.
- Maintain head elevation, neutral neck, avoid neck compression.
- Use steroids only for vasogenic edema (e.g., tumour, TB meningitis); not for traumatic brain injury.
- Monitoring –
- Neurological status (GCS) every hour.
- ICP waveform if drain in place; aim for ICP < 20 mmHg.
- Serum electrolytes, osmolality, renal function daily.
- Repeat imaging (CT/MRI) if neurological decline.
- Safety & contraindications
- Mannitol contraindicated in severe hypovolemia, renal failure, or pulmonary edema.
- Hypertonic saline contraindicated in hypernatremia > 155 mmol/L, severe heart failure.
- Hyperventilation beyond 30 min risks cerebral ischemia.
- Steroids contraindicated in bacterial meningitis caused by Listeria or in traumatic brain injury.
Complications and prognosis
| Complication | Mechanism | Clinical impact |
|---|---|---|
| Brain herniation | Uncontrolled ICP forces brain tissue across dural openings | Rapid loss of consciousness, pinpoint pupils, respiratory arrest – often fatal |
| Cerebral ischemia | Raised ICP reduces cerebral perfusion pressure | Permanent neurological deficit, infarction |
| Electrolyte derangements | Osmotherapy shifts water and ions | Hypernatremia, hypokalemia, renal impairment |
| Infection of CSF drain | Colonisation of external ventricular drain | Meningitis or ventriculitis |
| Seizures | Irritated cortex, metabolic disturbance | Additional ICP spikes, secondary injury |
| Long‑term neurocognitive deficits | Prolonged edema or infarction | Memory, executive function, motor deficits; prognosis depends on cause and speed of control |
Early recognition and rapid ICP reduction improve survival; outcome is best when the primary pathology (e.g., TB meningitis, malaria) is treated promptly.
High‑yield exam points
- Look‑alike conditions: Distinguish raised ICP from simple meningismus (neck stiffness without papilledema) and from metabolic encephalopathy (no focal signs, normal imaging).
- Commonest wrong first step: Giving high‑flow O₂ without securing the airway in a patient with GCS ≤ 8; examiners expect airway protection first.
- Bedside examiner questions:
- “What does a blown pupil tell you about the site of herniation?” – uncal (temporal) herniation compressing CN III.
- “Why do you elevate the head of the bed?” – to improve venous drainage and lower ICP.
- “When is hyperventilation appropriate and why must it be limited?” – as a temporising measure; prolonged hypocapnia causes cerebral ischemia.
- Key numbers: ICP > 20 mmHg is pathological; MAP – ICP > 60 mmHg is target cerebral perfusion pressure.
Clinical case
Case: A 28‑year‑old HIV‑positive male (CD4 = 120 cells/µL) presents with 3 days of worsening headache, vomiting, and confusion. On exam: GCS = 13 (E4 V4 M5), left‑sided papilledema, neck stiffness, and a right‑sided focal motor deficit (grade 3). CT brain shows a 2 cm ring‑enhancing lesion in the right frontal lobe with surrounding edema.
Questions
- What is the most urgent immediate intervention?
Answer: Secure the airway with endotracheal intubation and elevate the head of the bed to 30°.
- Which investigation will best differentiate toxoplasmosis from primary CNS lymphoma in this setting?
Answer: Serum/CSF PCR for Toxoplasma gondii and EBV DNA; a thallium‑SPECT or PET scan can also help, but PCR is the quickest.
- What is the definitive management plan if toxoplasmosis is confirmed?
Answer: Start anti‑toxoplasma therapy (pyrimethamine‑sulfadiazine or pyrimethamine‑clindamycin) plus adjunctive steroids for edema, and arrange follow‑up imaging in 2 weeks.
Practice questions
Question 1
A 45‑year‑old man with severe falciparum malaria is comatose (GCS = 7). His pupils are equal and reactive. CT is unavailable. What is the next best step?
A. Immediate lumbar puncture
B. Hyperventilate to PaCO₂ ≈ 30 mmHg for 1 hour
C. Give a bolus of mannitol
D. Start high‑dose steroids
Answer: C. give a bolus of mannitol
Explanation: Osmotherapy rapidly lowers ICP; lumbar puncture is contraindicated with possible raised ICP, hyperventilation is only a short‑term bridge, steroids have no role in malaria‑related edema.
Question 2
A child with sickle cell disease presents with headache, vomiting, and a GCS of 14. Fundoscopy shows papilledema. MRI reveals a small subdural hygroma. Which feature most strongly suggests that surgical drainage is required?
A. Age < 5 years
B. Presence of papilledema
C. Hygroma thickness > 10 mm
D. History of recent transfusion
Answer: C. hygroma thickness > 10 mm
Explanation: Large collections (>10 mm) are more likely to cause mass effect and need evacuation; papilledema alone does not dictate surgery.
Question 3
A patient with tuberculous meningitis is on standard anti‑TB drugs and dexamethasone. After 48 h his ICP remains > 25 mmHg despite mannitol. Which adjunct is most appropriate?
A. Add phenobarbital
B. Insert an external ventricular drain
C. Increase dexamethasone dose
D. Begin hypertonic saline infusion
Answer: B. insert an external ventricular drain
Explanation: Persistent high ICP despite medical therapy warrants CSF diversion; hypertonic saline is an alternative but drain provides continuous control.
Question 4
Which of the following is a contraindication to using hypertonic saline in a patient with raised ICP?
A. Serum sodium 148 mmol/L
B. Acute congestive heart failure with pulmonary edema
C. Controlled hypertension
D. Mild chronic kidney disease
Answer: B. acute congestive heart failure with pulmonary edema
Explanation: Hypertonic saline can worsen volume overload and pulmonary edema; other options are not absolute contraindications.
Question 5
During monitoring, a patient’s ICP waveform shows loss of the normal pulsatile pattern and a sustained plateau at 30 mmHg. What does this indicate?
A. Adequate ICP control
B. Impending herniation
C. Artifact from patient movement
D. Normal variation in children
Answer: B. impending herniation
Explanation: A plateau (non‑pulsatile) waveform signals loss of cerebral compliance and imminent herniation, demanding urgent decompression.
Drafted with AI assistance from standard references and reviewed for structure. Check details against your lecture notes and the Kenya MoH guideline.